Table 7 |
||||
|
Parasitic clearance |
||||
|
Treatment duration |
ASAQ1 (N = 310) |
ASAQ2 (N = 315) |
AL (N = 311) |
Total (N = 936) |
|
|
||||
|
Day 0 |
||||
|
N |
310 (100%) |
315 (100%) |
311 (100%) |
936 (100%) |
|
Density |
37781 ± 45652 |
41863 ± 49049 |
33958 ± 41474 |
37880 ± 45575 |
|
Day 1 |
||||
|
N |
198 (64.7%) |
194 (61.8%) |
206 (66.5%) |
598 (64.3%) |
|
Density |
3297 ± 8403 |
3137 ± 14753 |
3764 ± 14809 |
3406 ± 13002 |
|
Day 2 |
||||
|
N |
26 (8.6%) |
24 (7.7%) |
25 (8.1%) |
75 (8.1%) |
|
Density |
503 ± 787 |
914 ± 3230 |
1098 ± 2585 |
833 ± 2383 |
|
Day 3 |
||||
|
N |
None |
2 (0.6%) |
4 (1.3%) |
6 (0.7%) |
|
Density |
- |
154 ± 76 |
464 ± 296 |
361 ± 282 |
|
|
||||
|
Data are presented as the number of patients with parasites (N) and as the mean parasite density ± SD for the patients with parasitaemia. |
||||
|
Ndiaye et al. Malaria Journal 2009 8:125 doi:10.1186/1475-2875-8-125 |
||||